Implantable cardioverter-defibrillators in patients with COPD

Chest

Volumn 144, Issue 3, 2013, Pages 778-783

  Naksuk, Niyada ^a   Kunisaki, Ken M ^a   Benditt, David G ^a   Tholakanahalli, Venkatakrishna ^a   Adabag, Selcuk ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; CARDIAC RESYNCHRONIZATION THERAPY; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; FOLLOW UP; HEART FAILURE; HUMAN; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; IMPLANTATION; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; PRIMARY PREVENTION; PRIORITY JOURNAL; SHOCK; SPIROMETRY; SUDDEN CARDIAC DEATH;

EID: 84884295913     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.12-1883     Document Type: Article

References (36)

1. Murphy SL, Xu J, Kochanek KD. Deaths: preliminary data for 2010. Natl Vital Stat Rep. 2012 ; 60 (4): 1-51.
2. Buist AS, McBurnie MA, Vollmer WM, et al; BOLD Collaborative Research Group. International variation in the prevalence of COPD (the BOLD Study): a population-based prevalence study. Lancet. 2007 ; 370 (9589): 741-750.
3. Rutten FH, Cramer M-J, Grobbee DE, et al. Unrecognized heart failure in elderly patients with stable chronic obstructive pulmonary disease. Eur Heart J. 2005 ; 26 (18): 1887-1894.
4. Sin DD, Man SF. Chronic obstructive pulmonary disease as a risk factor for cardiovascular morbidity and mortality. Proc Am Thorac Soc. 2005 ; 2 (1): 8-11.
5. Adabag S, Roukoz H, Anand IS, Moss AJ. Cardiac resynchronization therapy in patients with minimal heart failure: a systematic review and meta-analysis. J Am Coll Cardiol. 2011 ; 58 (9): 935-941.
6. Adabag AS, Luepker RV, Roger VL, Gersh BJ. Sudden cardiac death: epidemiology and risk factors. Nat Rev Cardiol. 2010 ; 7 (4): 216-225.
7. Moss AJ, Zareba W, Hall WJ, et al ; Multicenter Automatic Defi brillator Implantation Trial II Investigators. Prophylactic implantation of a defi brillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med. 2002 ; 346 (12): 877-883.
8. Epstein AE, Dimarco JP, Ellenbogen KA, et al ; American College of Cardiology/American Heart Association Task Force on Practice ; American Association for Thoracic Surgery ; Society of Thoracic Surgeons. ACC/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: executive summary. Heart Rhythm. 2008 ; 5 (6): 934-955.
9. Bardy GH, Lee KL, Mark DB, et al ; Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT) Investigators. Amiodarone or an implantable cardioverter-defi brillator for congestive heart failure. N Engl J Med. 2005 ; 352 (3): 225-237.
10. Adabag AS, Wassif HS, Rice K, et al. Preoperative pulmonary function and mortality after cardiac surgery. Am Heart J. 2010 ; 159 (4): 691-697.
11. Pauwels RA, Buist AS, Ma P, Jenkins CR, Hurd SS ; GOLD Scientifi c Committee. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: National Heart, Lung, and Blood Institute and World Health Organization Global Initiative for Chronic Obstructive Lung Disease (GOLD): executive summary. Respir Care. 2001; 46 (8): 798-825.
12. Davis N, Xue Y, Roberts L, Massie B, Keung E. Remote monitoring of implantable cardioverter defi brillators: experience from the VA National ICD Surveillance Program. Heart Rhythm. 2005 ; 2 (suppl 5): S244.
13. Keung E, Xue Y. Remote web-based device monitoring. In Wang PJ, Naccarelli GV, Rosen MR, Estes NA III, Hayes DL, Haines DE, eds. New Arrhythmia Technologies. Malden, MA: Blackwell Publishing ; 2005 : 206-218.
14. Naksuk N, Adabag S. Application of the Multicenter Automatic Defi brillator Implantation Trial (MADIT) II risk score in a non-trial setting. Am J Cardiol. In press. doi:pii: S0002-9149(13)00993-4. 1016/j.amjcard.2013.04.019 15
15. Coumbe AG, Naksuk N, Newell MC, Somasundaram PE, Benditt DG, Adabag S. Long-term follow-up of older patients with Mobitz type I second degree atrioventricular block. Heart. 2013 ; 99 (5): 334-338.
16. Dougherty CM, Hunziker J. Predictors of implantable cardioverter defi brillator shocks during the fi rst year. J Cardiovasc Nurs. 2009 ; 24 (1): 21-28.
17. Razak E, Kamireddy S, Saba S. Implantable cardioverterdefi brillators confer survival benefi t in patients with chronic obstructive pulmonary disease. Pacing Clin Electrophysiol. 2010 ; 33 (9): 1125-1130.
18. Kleiger RE, Senior RM. Longterm electrocardiographic monitoring of ambulatory patients with chronic airway obstruction. Chest. 1974 ; 65 (5): 483-487.
19. Shih HT, Webb CR, Conway WA, Peterson E, Tilley B, Goldstein S. Frequency and signifi cance of cardiac arrhythmias in chronic obstructive lung disease. Chest. 1988 ; 94 (1): 44-48.
20. Fuso L, Incalzi RA, Pistelli R, et al. Predicting mortality of patients hospitalized for acutely exacerbated chronic obstructive pulmonary disease. Am J Med. 1995 ; 98 (3): 272-277.
21. McGarvey LP, Magder S, Burkhart D, et al. Cause-specifi c mortality adjudication in the UPLIFT® COPD trial: fi ndings and recommendations. Respir Med. 2012 ; 106 (4): 515-521.
22. Tashkin DP, Celli B, Senn S, et al ; UPLIFT Study Investigators. A 4-year trial of tiotropium in chronic obstructive pulmonary disease. N Engl J Med. 2008 ; 359 (15): 1543-1554.
23. Anand IS, Chandrashekhar Y, Ferrari R, et al. Pathogenesis of congestive state in chronic obstructive pulmonary disease. Studies of body water and sodium, renal function, hemodynamics, and plasma hormones during edema and after recovery. Circulation. 1992 ; 86 (1): 12-21.
24. Incalzi RA, Pistelli R, Fuso L, Cocchi A, Bonetti MG, Giordano A. Cardiac arrhythmias and left ventricular function in respiratory failure from chronic obstructive pulmonary disease. Chest. 1990 ; 97 (5): 1092-1097.
25. Au DH, Udris EM, Fan VS, Curtis JR, McDonell MB, Fihn SD. Risk of mortality and heart failure exacerbations associated with inhaled beta-adrenoceptor agonists among patients with known left ventricular systolic dysfunction. Chest. 2003 ; 123 (6): 1964-1969.
26. Salpeter SR, Ormiston TM, Salpeter EE. Cardiovascular effects of beta-agonists in patients with asthma and COPD: a metaanalysis. Chest. 2004 ; 125 (6): 2309-2321.
27. Wathen MS, DeGroot PJ, Sweeney MO, et al ; PainFREE Rx II Investigators. Prospective randomized multicenter trial of empirical antitachycardia pacing versus shocks for spontaneous rapid ventricular tachycardia in patients with implantable cardioverter-defi brillators: Pacing Fast Ventricular Tachycardia Reduces Shock Therapies (PainFREE Rx II) trial results. Circulation. 2004 ; 110 (17): 2591-2596.
28. Moss AJ, Schuger C, Beck CA, et al ; MADIT-RIT Trial Investigators. Reduction in inappropriate therapy and mortality through ICD programming. N Engl J Med. 2012 ; 367 (24): 2275-2283.
29. Wilkoff BL, Williamson BD, Stern RS, et al ; PREPARE Study Investigators. Strategic programming of detection and therapy parameters in implantable cardioverter-defi brillators reduces shocks in primary prevention patients: results from the PREPARE (Primary Prevention Parameters Evaluation) study. J Am Coll Cardiol. 2008 ; 52 (7): 541-550.
30. Wilkoff BL, Ousdigian KT, Sterns LD, Wang ZJ, Wilson RD, Morgan JM ; EMPIRIC Trial Investigators. A comparison of empiric to physician-tailored programming of implantable cardioverter-defi brillators: results from the prospective randomized multicenter EMPIRIC trial. J Am Coll Cardiol. 2006 ; 48 (2): 330-339.
31. van Rees JB, Borleffs CJ, de Bie MK, et al. Inappropriate implantable cardioverter-defi brillator shocks: incidence, predictors, and impact on mortality. J Am Coll Cardiol. 2011 ; 57 (5): 556-562.
32. Daubert JP, Zareba W, Cannom DS, et al ; MADIT II Investigators. Inappropriate implantable cardioverter-defi brillator shocks in MADIT II: frequency, mechanisms, predictors, and survival impact. J Am Coll Cardiol. 2008 ; 51 (14): 1357-1365.
33. Damarla M, Celli BR, Mullerova HX, Pinto-Plata VM. Discrepancy in the use of confi rmatory tests in patients hospitalized with the diagnosis of chronic obstructive pulmonary disease or congestive heart failure. Respir Care. 2006 ; 51 (10): 1120-1124.
34. Mannino DM, Gagnon RC, Petty TL, Lydick E. Obstructive lung disease and low lung function in adults in the United States: data from the National Health and Nutrition Examination Survey, 1988-1994. Arch Intern Med. 2000; 160(11): 1683-1689.
35. Tinkelman DG, Price DB, Nordyke RJ, Halbert RJ. Misdiagnosis of COPD and asthma in primary care patients 40 years of age and over. J Asthma. 2006 ; 43 (1): 75-80.
36. Germano JJ, Reynolds M, Essebag V, Josephson ME. Frequency and causes of implantable cardioverter-defi brillator therapies: is device therapy proarrhythmic? Am J Cardiol. 2006 ; 97 (8): 1255-1261.